Trial Profile

A Study to Evaluate the Safety and Efficacy of Omnitrope in Adult Patients with Growth Hormone Deficiency

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 15 Jun 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Somatropin (Primary)
Indications Growth disorders
Focus Adverse reactions; Therapeutic Use
Acronyms PATRO Adults

Most Recent Events

07 Jun 2020 Results of snapshot analysis in italian population (n=88; as of Aug 2017) published in the Journal of Endocrinological Investigation.
18 Mar 2019 Interim results assessing safety outcomes in terms of diabetes risk (as of Sep 2018; n=1298) presented at the 101st Annual Meeting of the Endocrine Society.
20 Mar 2018 Results (n=1241, data cut off: October 2017) presented at The 100th Annual Meeting of the Endocrine Society

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com